Jamjoom Pharma board OKs 10% dividend for H1 2023

10/08/2023 Argaam Exclusive

The board of Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) declared, on Aug. 9, a 10% cash dividend, or SAR 1 per share, for the first half of 2023, the company said in a statement to Tadawul.

 

Dividend Details (H1 2023)

Current Capital

SAR 700 mln

Number of shares

70 mln

Dividend

SAR 70 mln

Percentage of capital

10% (SAR 1 per share)

Record date

Aug. 20, 2023 (Shareholders registered with Edaa by the close of the second trading day following the record date)

Payment date

Sept. 3, 2023

 

This is the first payout by the company, which listed shares on the Saudi Exchange (Tadawul) last June.

Dividend History (SAR/share) Corporate Actions

Announcement Ex-Dividend Payment Dividends
(M Riyal)
Dividends * Notes
10/08/2023 20/08/2023 03/09/2023 70.00 1.00
Historical dividend per share adjusted for the effect of capital changes and bonus shares, if any

Dividend History

Consolidated cash dividend Cash dividend per share (SAR) * The stock price at the beginning of the period (SAR) Return on the base price
Last 3 Financial years N/A N/A N/A
Last 5 Financial years N/A N/A N/A
Last 10 Financial years N/A N/A N/A
Based on the beginning of the period (January 1 of the base year)

Historical Dividends

ajax loading

Valuation Data (Latest Share Price)

P/E (TTM) 29.49
P/E Before Unusual Items (TTM) 29.49
P/BV 6.27
Dividend Yield 2.17 %
Market Cap. (M) 9,170.00
Return on Average Assets 19.12 %
Return on Average Equity 22.77 %

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.